UNSPSC 51393201: Tiamenidine

This classification denotes an alpha-adrenergic agonist with the molecular formula C8H10ClN3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 195V08O55G, chemically known as 2-imidazoline, 2-((2-chloro-4-methyl-3-thienyl)amino)-, monohydrochloride but generally known as tiamenidine, which bears US NIH Compound Identifier 39973. European Medicines Agency schedules Tiamenidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11001MIG.

UNSPSC 51393201 Tiamenidine is a Commodity code whose recent procurement activity centers on pharmaceutical products — specifically naloxone and drug deactivation systems — rather than tiamenidine itself as the nominal code name might suggest. State and local governments soliciting under this code are purchasing pharmaceutical interventions and harm-reduction supplies to support community health, public safety, and pharmacy benefit programs. The issuing bodies include county health departments (Seminole County, Florida) and state health and human services commissions (Texas HHS Commission), reflecting a mix of local and state-level health and safety procurement.

Seminole County, Florida and Texas dominate recent activity. Seminole County posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023; the contract carries a two-year initial term with a one-year renewal option and requires E-Verify compliance, workers' compensation insurance, and commercial general liability coverage. Texas HHS Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities on direct-to-manufacturer prescription fulfillment and therapeutic pharmacy initiatives, seeking information on vendors' experience with direct contracting for self-insured employers and state agencies, value-based agreements, and negotiated net pricing models without rebates — this RFI is exploratory in nature and designed to inform future formal solicitation strategy rather than award a contract immediately.